Anti-Aβ Autoantibodies in Amyloid Related Imaging Abnormalities (ARIA): Candidate Biomarker for Immunotherapy in Alzheimer’s Disease and Cerebral Amyloid Angiopathy-Reference-Cited by-同舟云学术

Anti-Aβ Autoantibodies in Amyloid Related Imaging Abnormalities (ARIA): Candidate Biomarker for Immunotherapy in Alzheimer’s Disease and Cerebral Amyloid Angiopathy

Published:2015-09-25 Issue: Volume:6 Page:
ISSN:1664-2295
Container-title:Frontiers in Neurology
language:
Short-container-title:Front. Neurol.

Author:

DiFrancesco Jacopo C.,Longoni Martina,Piazza Fabrizio

Publisher

Frontiers Media SA

Subject

Neurology (clinical),Neurology

Reference50 articles.

1. Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases;Lleo;Nat Rev Neurol,2015

3. MR imaging features of amyloid-related imaging abnormalities;Barakos;AJNR Am J Neuroradiol,2013

4. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer’s disease;Salloway;N Engl J Med,2014

5. A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease;Salloway;Neurology,2009

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cerebral amyloid angiopathy and the immune system;Alzheimer's & Dementia;2024-06-17

2. Efficacy and safety of gantenerumab in the treatment of Alzheimer's disease: A meta-analysis of randomized controlled trials;Archives of Gerontology and Geriatrics Plus;2024-06

3. Immunotherapy in Alzheimer’s disease: focusing on the efficacy of gantenerumab on amyloid-β clearance and cognitive decline;Journal of Pharmacy and Pharmacology;2024-05-20

4. Ion transporter cascade, reactive astrogliosis and cerebrovascular diseases;Frontiers in Pharmacology;2024-04-09

5. Controversial Past, Splendid Present, Unpredictable Future: A Brief Review of Alzheimer Disease History;Journal of Clinical Medicine;2024-01-17